AlloMek Therapeutics' Debt Round

AlloMek Therapeutics raised a round of funding on February 06, 2017.

AlloMek Therapeutics, formerly AlloStem Therapeutics, is an early-stage pharmaceutical company committed to helping cancer patients by developing macrocyclic small molecule inhibitors that target vari…

Articles about AlloMek Therapeutics' Debt Round: